#GreenInnovationForum | “To move toward net-zero emissions in healthcare, at AstraZeneca w... 12/11/2024 Healthcare Innovative drugs International We interviewed Marta Moreno, Director of Corporate Affairs and Market Access at AstraZeneca Spain, Bronze Sponsor of the... AseBio
The Fight Against Pneumonia and Antibiotic Resistance: Vaxdyn and the K-Vax Vaccine Candid... 11/11/2024 Healthcare Access to innovation Innovative drugs On the occasion of World Pneumonia Day, we interviewed Juanjo Infante, CEO of Vaxdyn, a biotech company developing the K... Partners
Access to Innovative Therapies in Spain: Challenges and Opportunities 07/11/2024 Healthcare Access to innovation Innovative drugs Advanced therapies International In this article, Chus Castillo, Partner Consulting Iberia at Alira Health, and Ion Arocena, General Manager at AseBio... Partners - Alira Health
AI in Drug Developement: Transforming Drug Discovery and Repurposing Online Del 22/11/2024 11:00 to 22/11/2024 Healthcare Innovative drugs Communication
INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer In... 29/10/2024 Healthcare Access to innovation Innovative drugs VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation... Partners - Asabys Partners
Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European ... 23/10/2024 Healthcare Access to innovation Innovative drugs Partners - THERIVA BIOLOGICS S.L.
ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic ... 18/10/2024 Healthcare Innovative drugs ATX-01 is the industry’s first anti-microRNA therapeutic to be investigated in DM1 Partners - ARTHEx Biotech
ORYZON announces formal grant of key European patent for vafidemstat 14/10/2024 Healthcare Innovative drugs International EU projects For the treatment of aggression and social withdrawal. Partners - Oryzon Genomics
AEMPS approves Peaches' clinical trial with selective secretomes to treat COVID-19-associa... 10/10/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will help combat cytokine storm, a... Partners - PEACHES BIOTECH S.L.
"ApToll is an immune modulator to treat ischaemic stroke in the acute phase. We have suc... 10/10/2024 Healthcare Innovative drugs David Segarra, an aptamer technology entrepreneur, co-founded aptaTargets in 2014 and has led the company to bring... Partners - GENESIS Biomed
